Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
BioForce Nanosciences Holdings Inc. (BFNH) Stock-Based Compensation data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-0.49M |
|
-- |
|
-- |
|
$0.49M |
|
$-0.49M |
|
-- |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
29.27M |
|
29.27M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$2.30M |
|
-- |
|
-- |
|
$2.30M |
|
$-2.30M |
|
$-2.30M |
|
$-2.30M |
|
29.27M |
|
| Cash Flow Statement Financials | |
$-0.06M |
|
-- |
|
$0.06M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
21.31% |
|
21.31% |
|
-- |
|
21.31% |
|
$-0.08 |
|
$-0.00 |
|
$-0.00 |
|